PURPOSE: To assess the validity of the Patient Activation Measure (PAM13) of patient activation in persons with neurological conditions. METHODS: "The Everyday Experience of Living with and Managing a Neurological Condition" (The LINC study) surveyed 948 adults with neurological conditions residing in Canada in 2011 and 2012. Using data for 722 respondents who met coding requirements for the PAM-13, we examined the properties of the measure using principle components analysis, inter-item correlations and Cronbach's alpha to assess unidimensionality and internal consistency. Rasch modeling was used to assess item performance and scaling. Construct validity was assessed by calculating associations between the PAM and known correlates. RESULTS: PAM-13 provides a suitably reliable and valid instrument for research in patients with neurological conditions, but scaling problems may yield measurement error and biases for those with low levels of activation. This is of particular importance when used in clinical settings or for individual client care. Our study also suggests that measurement of activation may benefit from tailoring items and scaling to specific diagnostic groups such as people with neurological conditions, thus allowing the PAM-13 to recognize unique attributes and management challenges in those conditions. CONCLUSIONS: The PAM-13 is an internally reliable and valid tool for research purposes. The use of categorical activation "level" in clinical settings should be done with caution.
PURPOSE: To assess the validity of the Patient Activation Measure (PAM13) of patient activation in persons with neurological conditions. METHODS: "The Everyday Experience of Living with and Managing a Neurological Condition" (The LINC study) surveyed 948 adults with neurological conditions residing in Canada in 2011 and 2012. Using data for 722 respondents who met coding requirements for the PAM-13, we examined the properties of the measure using principle components analysis, inter-item correlations and Cronbach's alpha to assess unidimensionality and internal consistency. Rasch modeling was used to assess item performance and scaling. Construct validity was assessed by calculating associations between the PAM and known correlates. RESULTS:PAM-13 provides a suitably reliable and valid instrument for research in patients with neurological conditions, but scaling problems may yield measurement error and biases for those with low levels of activation. This is of particular importance when used in clinical settings or for individual client care. Our study also suggests that measurement of activation may benefit from tailoring items and scaling to specific diagnostic groups such as people with neurological conditions, thus allowing the PAM-13 to recognize unique attributes and management challenges in those conditions. CONCLUSIONS: The PAM-13 is an internally reliable and valid tool for research purposes. The use of categorical activation "level" in clinical settings should be done with caution.
Authors: Richard L Skolasky; Ariel Frank Green; Daniel Scharfstein; Chad Boult; Lisa Reider; Stephen T Wegener Journal: Health Serv Res Date: 2010-11-19 Impact factor: 3.402
Authors: Mathew R Guilfoyle; Helen M Seeley; Elizabeth Corteen; Christine Harkin; Hugh Richards; David K Menon; Peter J Hutchinson Journal: J Neurotrauma Date: 2010-12 Impact factor: 5.269
Authors: Joan Versnel; Tanya Packer; Lori E Weeks; Jocelyn Brown; Marshall Godwin; Susan Hutchinson; George Kephart; Diane MacKenzie; Kerstin Roger; Robin Stadnyk; Michelle Villeneuve; Grace Warner Journal: BMC Neurol Date: 2013-03-21 Impact factor: 2.474
Authors: Bi Xia Ngooi; Tanya L Packer; George Kephart; Grace Warner; Karen Wei Ling Koh; Raymond Ching Chiew Wong; Serene Peiying Lim Journal: Qual Life Res Date: 2016-09-19 Impact factor: 4.147
Authors: N H Bahrom; A S Ramli; M R Isa; N Baharudin; S F Badlishah-Sham; M S Mohamed-Yassin; H Abdul-Hamid Journal: Malays Fam Physician Date: 2020-11-10
Authors: Courtney J Lightfoot; Thomas J Wilkinson; Katherine E Memory; Jared Palmer; Alice C Smith Journal: Clin J Am Soc Nephrol Date: 2021-06-11 Impact factor: 10.614
Authors: Jackie Sturt; Thandiwe Rebecca Dliwayo; Vera Forjaz; Kathryn Hamilton; Carol Bryce; Joseph Fraser; Frances Griffiths Journal: J Med Internet Res Date: 2018-10-11 Impact factor: 5.428